Baidu
map

Ann Med:福建省立医院朱鹏立发现Apelin或是潜在的降压治疗靶点

2013-12-27 desperado-c dxy

研究要点:1.该研究探讨中国沿海居民血浆apelin水平与血压的关系;2.发现收缩压、舒张压和平均动脉血压与apelin水平呈显著负相关。为了描述中国沿海居民血浆apelin水平与血压的关系,来自中国福建医科大学附属福建省立医院老年科朱鹏立教授及其团队进行了一项研究,该研究发现中国沿海居民血浆apelin水平与血压呈负相关。该研究结果发表在2013年11月的Annals of medicine杂志

研究要点:1.该研究探讨中国沿海居民血浆apelin水平与血压的关系;2.发现收缩压、舒张压和平均动脉血压与apelin水平呈显著负相关。为了描述中国沿海居民血浆apelin水平与血压的关系,来自中国福建医科大学附属福建省立医院老年科朱鹏立教授及其团队进行了一项研究,该研究发现中国沿海居民血浆apelin水平与血压呈负相关。该研究结果发表在2013年11月的Annals of medicine杂志上,该杂志影响因子为5.094。该研究是一项横断面研究,在中国沿海地区共招募了1031例受试者。使用单因素方差分析(ANOVA)、线性趋势检验、 Pearson相关分析、以及多元线性回归分析评估血浆apelin水平与血压之间的关系。【原文下载】该研究结果表明,随着收缩压(SBP)、舒张压(DBP)和平均动脉血压(MABP)的四分位数增加,血浆apelin水平下降。随着apelin水平在四分位数内增加,SBP、DBP和MABP值下降。校正年龄和性别后,apelin四分位数不同组之间SBP、DBP和MABP仍有显著差异。该研究观察到SBP、DBP以及MABP与apelin水平呈显著负相关;即使在校

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2036581, encodeId=9424203658128, content=<a href='/topic/show?id=2dfd2634c7' target=_blank style='color:#2F92EE;'>#Apelin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2634, encryptionId=2dfd2634c7, topicName=Apelin)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Wed Sep 03 11:43:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725562, encodeId=8b911e255629e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Nov 29 03:43:00 CST 2014, time=2014-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655064, encodeId=d57f16550645b, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Wed Feb 05 10:43:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895305, encodeId=06f11895305de, content=<a href='/topic/show?id=18ae64e21d3' target=_blank style='color:#2F92EE;'>#治疗靶点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64721, encryptionId=18ae64e21d3, topicName=治疗靶点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Feb 06 07:43:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291808, encodeId=bc9b129180849, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360837, encodeId=e659136083eff, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606077, encodeId=be4716060e77f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625819, encodeId=8c071625819be, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=)]
    2014-09-03 qindq
  2. [GetPortalCommentsPageByObjectIdResponse(id=2036581, encodeId=9424203658128, content=<a href='/topic/show?id=2dfd2634c7' target=_blank style='color:#2F92EE;'>#Apelin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2634, encryptionId=2dfd2634c7, topicName=Apelin)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Wed Sep 03 11:43:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725562, encodeId=8b911e255629e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Nov 29 03:43:00 CST 2014, time=2014-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655064, encodeId=d57f16550645b, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Wed Feb 05 10:43:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895305, encodeId=06f11895305de, content=<a href='/topic/show?id=18ae64e21d3' target=_blank style='color:#2F92EE;'>#治疗靶点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64721, encryptionId=18ae64e21d3, topicName=治疗靶点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Feb 06 07:43:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291808, encodeId=bc9b129180849, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360837, encodeId=e659136083eff, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606077, encodeId=be4716060e77f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625819, encodeId=8c071625819be, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=)]
    2014-11-29 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=2036581, encodeId=9424203658128, content=<a href='/topic/show?id=2dfd2634c7' target=_blank style='color:#2F92EE;'>#Apelin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2634, encryptionId=2dfd2634c7, topicName=Apelin)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Wed Sep 03 11:43:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725562, encodeId=8b911e255629e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Nov 29 03:43:00 CST 2014, time=2014-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655064, encodeId=d57f16550645b, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Wed Feb 05 10:43:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895305, encodeId=06f11895305de, content=<a href='/topic/show?id=18ae64e21d3' target=_blank style='color:#2F92EE;'>#治疗靶点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64721, encryptionId=18ae64e21d3, topicName=治疗靶点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Feb 06 07:43:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291808, encodeId=bc9b129180849, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360837, encodeId=e659136083eff, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606077, encodeId=be4716060e77f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625819, encodeId=8c071625819be, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=)]
    2014-02-05 ewsr9
  4. [GetPortalCommentsPageByObjectIdResponse(id=2036581, encodeId=9424203658128, content=<a href='/topic/show?id=2dfd2634c7' target=_blank style='color:#2F92EE;'>#Apelin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2634, encryptionId=2dfd2634c7, topicName=Apelin)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Wed Sep 03 11:43:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725562, encodeId=8b911e255629e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Nov 29 03:43:00 CST 2014, time=2014-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655064, encodeId=d57f16550645b, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Wed Feb 05 10:43:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895305, encodeId=06f11895305de, content=<a href='/topic/show?id=18ae64e21d3' target=_blank style='color:#2F92EE;'>#治疗靶点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64721, encryptionId=18ae64e21d3, topicName=治疗靶点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Feb 06 07:43:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291808, encodeId=bc9b129180849, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360837, encodeId=e659136083eff, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606077, encodeId=be4716060e77f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625819, encodeId=8c071625819be, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2036581, encodeId=9424203658128, content=<a href='/topic/show?id=2dfd2634c7' target=_blank style='color:#2F92EE;'>#Apelin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2634, encryptionId=2dfd2634c7, topicName=Apelin)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Wed Sep 03 11:43:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725562, encodeId=8b911e255629e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Nov 29 03:43:00 CST 2014, time=2014-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655064, encodeId=d57f16550645b, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Wed Feb 05 10:43:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895305, encodeId=06f11895305de, content=<a href='/topic/show?id=18ae64e21d3' target=_blank style='color:#2F92EE;'>#治疗靶点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64721, encryptionId=18ae64e21d3, topicName=治疗靶点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Feb 06 07:43:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291808, encodeId=bc9b129180849, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360837, encodeId=e659136083eff, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606077, encodeId=be4716060e77f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625819, encodeId=8c071625819be, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2036581, encodeId=9424203658128, content=<a href='/topic/show?id=2dfd2634c7' target=_blank style='color:#2F92EE;'>#Apelin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2634, encryptionId=2dfd2634c7, topicName=Apelin)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Wed Sep 03 11:43:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725562, encodeId=8b911e255629e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Nov 29 03:43:00 CST 2014, time=2014-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655064, encodeId=d57f16550645b, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Wed Feb 05 10:43:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895305, encodeId=06f11895305de, content=<a href='/topic/show?id=18ae64e21d3' target=_blank style='color:#2F92EE;'>#治疗靶点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64721, encryptionId=18ae64e21d3, topicName=治疗靶点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Feb 06 07:43:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291808, encodeId=bc9b129180849, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360837, encodeId=e659136083eff, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606077, encodeId=be4716060e77f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625819, encodeId=8c071625819be, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2036581, encodeId=9424203658128, content=<a href='/topic/show?id=2dfd2634c7' target=_blank style='color:#2F92EE;'>#Apelin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2634, encryptionId=2dfd2634c7, topicName=Apelin)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Wed Sep 03 11:43:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725562, encodeId=8b911e255629e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Nov 29 03:43:00 CST 2014, time=2014-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655064, encodeId=d57f16550645b, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Wed Feb 05 10:43:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895305, encodeId=06f11895305de, content=<a href='/topic/show?id=18ae64e21d3' target=_blank style='color:#2F92EE;'>#治疗靶点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64721, encryptionId=18ae64e21d3, topicName=治疗靶点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Feb 06 07:43:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291808, encodeId=bc9b129180849, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360837, encodeId=e659136083eff, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606077, encodeId=be4716060e77f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625819, encodeId=8c071625819be, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2036581, encodeId=9424203658128, content=<a href='/topic/show?id=2dfd2634c7' target=_blank style='color:#2F92EE;'>#Apelin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2634, encryptionId=2dfd2634c7, topicName=Apelin)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Wed Sep 03 11:43:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725562, encodeId=8b911e255629e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Nov 29 03:43:00 CST 2014, time=2014-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655064, encodeId=d57f16550645b, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Wed Feb 05 10:43:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895305, encodeId=06f11895305de, content=<a href='/topic/show?id=18ae64e21d3' target=_blank style='color:#2F92EE;'>#治疗靶点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64721, encryptionId=18ae64e21d3, topicName=治疗靶点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Feb 06 07:43:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291808, encodeId=bc9b129180849, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360837, encodeId=e659136083eff, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606077, encodeId=be4716060e77f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625819, encodeId=8c071625819be, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Sun Dec 29 01:43:00 CST 2013, time=2013-12-29, status=1, ipAttribution=)]
    2013-12-29 tidiq
Baidu
map
Baidu
map
Baidu
map